PAI
BLUE

Palo Alto Investors’s bluebird bio BLUE Stock Holding History

Palo Alto Investors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,213
Closed -$314K – 44
2024
Q3 		$314K Sell
30,213
-201,455
-87% -$3.35M 0.04% 43
2024
Q2 		$4.56M Buy
231,668
+3,659
+2% +$73.3K 0.53% 25
2024
Q1 		$5.84M Buy
228,009
+61,342
+37% +$1.57M 0.66% 27
2023
Q4 		$4.6M Buy
+166,667
New +$10.2M 0.41% 24

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Palo Alto Investors's BLUE Position: Q4 2024 in Review

Palo Alto Investors sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 30,213 shares — an estimated $314K sold.

Palo Alto Investors first reported a position in BLUE in Q4 2023 and held it in 4 quarters. The position peaked at $5.84M in Q1 2024. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Palo Alto Investors reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Palo Alto Investors sold 30,213 bluebird bio shares in Q4 2024, an estimated $314K.
  • Palo Alto Investors first reported a position in bluebird bio in Q4 2023 and held it in 4 quarters.
  • Palo Alto Investors's bluebird bio position peaked at $5.84M in Q1 2024.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Palo Alto Investors's 13F filing for Q4 2024, filed 14 Feb 2025.